Loading...
Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma
Testing of the MGMT promoter methylation status in glioblastoma is relevant for clinical decision making and research applications. Two recent and independent phase III therapy trials confirmed a prognostic and predictive value of the MGMT promoter methylation status in elderly glioblastoma patients...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dustri-Verlag Dr. Karl Feistle
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3891253/ https://ncbi.nlm.nih.gov/pubmed/24359605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/NP300730 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|